O-022Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

O-022Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; no. Supplement_4
Main Authors: Miksad, R, Cicin, I, Chen, Y, Klumpen, H, Kim, S, Lin, Z, Youkstetter, J, Sen, S, Cheng, A, Meyer, T, Kelley, R, Abou-Alfa, G
Format: Journal Article
Language:English
Published: Oxford University Press 01-07-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz154.021